Regeneron CEO Schleifer: Drug Pricing Conundrum

The transcript discusses the balance between making drugs affordable and ensuring sufficient investment in the biopharmaceutical industry. It highlights the importance of the patent system in fostering innovation, particularly in the United States, and addresses concerns about political influences on drug pricing and patents. The speaker also touches on challenges within the pharmaceutical industry, emphasizing that while there are bad actors, the industry is crucial for healthcare solutions. Finally, the role of the FDA in maintaining high standards for drug safety and efficacy is explored, contrasting the needs of large marketing companies with those of innovative firms.

What is the speaker's view on the relationship between the pharmaceutical industry and healthcare problems?

What role does the FDA play in the drug approval process according to the speaker?